The Effects of Tamoxifen and Fish Oil on Mammary Carcinogenesis in Polyoma Middle T Transgenic Mice

[1]  Richard D Bruggeman,et al.  The Impact of Fish Oil on the Chemopreventive Efficacy of Tamoxifen against Development of N-Methyl-N-Nitrosourea–Induced Rat Mammary Carcinogenesis , 2010, Cancer Prevention Research.

[2]  J. V. Vanden Heuvel,et al.  Regulation of Peroxisome Proliferator-Activated Receptors by E6-Associated Protein , 2008, PPAR research.

[3]  Ka Chen,et al.  Effects of Different Dietary Fatty Acids on the Fatty Acid Compositions and the Expression of Lipid Metabolic-Related Genes in Mammary Tumor Tissues of Rats , 2008, Nutrition and cancer.

[4]  W. Mojica,et al.  Effects of omega-3 fatty acids on cancer risk: a systematic review. , 2006, JAMA.

[5]  L. Hilakivi-Clarke,et al.  Opposing effects of prepubertal low- and high-fat n-3 polyunsaturated fatty acid diets on rat mammary tumorigenesis. , 2005, Carcinogenesis.

[6]  S. Catalano,et al.  Estrogen Receptor α Binds to Peroxisome Proliferator–Activated Receptor Response Element and Negatively Interferes with Peroxisome Proliferator–Activated Receptor γ Signaling in Breast Cancer Cells , 2005, Clinical Cancer Research.

[7]  T. Rosol,et al.  Dietary (n-3) polyunsaturated fatty acids inhibit HER-2/neu-induced breast cancer in mice independently of the PPARgamma ligand rosiglitazone. , 2005, The Journal of nutrition.

[8]  F. Kittrell,et al.  Tamoxifen inhibition of estrogen receptor-α-negative mouse mammary tumorigenesis , 2005 .

[9]  R. Schiff,et al.  Crosstalk between estrogen receptor and growth factor receptor pathways as a cause for endocrine therapy resistance in breast cancer. , 2005, Clinical Cancer Research.

[10]  S. Johnston.  Combinations of endocrine and biological agents: present status of therapeutic and presurgical investigations. , 2005, Clinical Cancer Research.

[11]  Jeffrey W Pollard,et al.  Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases. , 2003, The American journal of pathology.

[12]  P. Musiani,et al.  Prevention of HER‐2/neu transgenic mammary carcinoma by tamoxifen plus interleukin 12 , 2003, International Journal of Cancer.

[13]  C. Dabrosin,et al.  Estradiol Promotes Growth and Angiogenesis in Polyoma Middle T Transgenic Mouse Mammary Tumor Explants , 2003, Breast Cancer Research and Treatment.

[14]  Xin Wang,et al.  Signal cross-talk between estrogen receptor alpha and beta and the peroxisome proliferator-activated receptor gamma1 in MDA-MB-231 and MCF-7 breast cancer cells , 2002, Molecular and Cellular Endocrinology.

[15]  M. Belanger,et al.  Body weight and food intake profiles are modulated by sex hormones and tamoxifen in chronically hypertensive rats. , 2002, Journal of NutriLife.

[16]  M. Belanger,et al.  Sex hormones and the selective estrogen receptor modulator tamoxifen modulate weekly body weights and food intakes in adolescent and adult rats. , 2001, The Journal of nutrition.

[17]  S. Fuqua,et al.  Histological and biological evolution of human premalignant breast disease. , 2001, Endocrine-related cancer.

[18]  C K Redmond,et al.  Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. , 1999, Journal of the National Cancer Institute.

[19]  S. Cummings,et al.  The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation. , 1999, JAMA.

[20]  S. Haslam,et al.  The role of ovarian hormones, age and mammary gland development in polyomavirus mammary tumorigenesis. , 1995, Oncogene.

[21]  T. Orton,et al.  Two-year carcinogenicity study of tamoxifen in Alderley Park Wistar-derived rats. , 1993, Cancer research.

[22]  D. Sepkovic,et al.  Effect of varying proportions of dietary menhaden and corn oil on experimental rat mammary tumor promotion , 1993, Lipids.

[23]  R. Cardiff,et al.  Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease , 1992, Molecular and cellular biology.

[24]  S. Serini,et al.  Dietary omega-3 polyunsaturated fatty acids and cancer , 2010 .

[25]  I. Berquin,et al.  ω-3 PUFAs, Breast and Prostate Cancer: Experimental Studies , 2010 .

[26]  M. Sawyer,et al.  Possible Mechanisms of ω-3 PUFA Anti-tumour Action , 2010 .

[27]  C. Ruxton,et al.  The health benefits of omega-3 polyunsaturated fatty acids: a review of the evidence. , 2007, Journal of human nutrition and dietetics : the official journal of the British Dietetic Association.

[28]  S. Catalano,et al.  Estrogen receptor alpha binds to peroxisome proliferator-activated receptor response element and negatively interferes with peroxisome proliferator-activated receptor gamma signaling in breast cancer cells. , 2005, Clinical Cancer Research.

[29]  F. Kittrell,et al.  Tamoxifen inhibition of estrogen receptor-alpha-negative mouse mammary tumorigenesis. , 2005, Cancer research.

[30]  S. Ménard,et al.  Advances in Brief Tamoxifen Chemoprevention of a Hormone-independent Tumor in the Proto-neu Transgenic Mice Model 1 , 2000 .

[31]  Y. Kanke,et al.  Effects of dietary n-3-to-n-6 polyunsaturated fatty acid ratio on mammary carcinogenesis in rats. , 1998, Nutrition and cancer.

[32]  G. Lepage,et al.  Direct transesterification of all classes of lipids in a one-step reaction. , 1986, Journal of lipid research.